Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Cindy L. Schwartz MD

Cindy L. Schwartz MD

Chief, Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology and Oncology - Pediatrics
Program: Hematology

Member of the Cancer Center


Publications

  • Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group. (Marks LJ, Pei Q, Bush R, Buxton A, Appel B, Kelly KM, Schwartz CL, Friedman DL) Pediatr Blood Cancer 2018 Dec;65(12):e27375 PMID: 30277639 PMCID: PMC6192844 10/03/2018    
  • Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group. (Spraker-Perlman HL, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Doski J, Gorlick R, Janeway KA, Isakoff MS) Pediatr Blood Cancer 2019 Jan;66(1):e27444 PMID: 30255612 PMCID: PMC6249072 09/27/2018    
  • Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol. (Marks LJ, McCarten KM, Pei Q, Friedman DL, Schwartz CL, Kelly KM) Blood 2018 Sep 13;132(11):1208-1211 PMID: 30061157 PMCID: PMC6137557 08/01/2018    
  • Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children's Oncology Group protocol AHOD0031. (McCarten KM, Metzger ML, Drachtman RA, Pei Q, Friedman DL, Schwartz CL, Kelly KM) Pediatr Radiol 2018 11;48(12):1736-1744 PMID: 30014200 PMCID: PMC6208959 07/18/2018       1 Citations
  • Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group. (Keller FG, Castellino SM, Chen L, Pei Q, Voss SD, McCarten KM, Senn SL, Buxton AB, Bush R, Constine LS, Schwartz CL) Cancer 2018 Aug 01;124(15):3210-3219 PMID: 29738613 PMCID: PMC6097921 05/09/2018    
  • Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031. (Parzuchowski A, Bush R, Pei Q, Friedman DL, FitzGerald TJ, Wolden SL, Dharmarajan KV, Constine LS, Laurie F, Kessel SK, Appel B, Fernandez K, Punnett A, Schwartz CL, Cox J, Terezakis SA) Int J Radiat Oncol Biol Phys 2018 Apr 01;100(5):1119-1125 PMID: 29722656 05/04/2018    
  • Surgeon Concordance in the Assessment of Resectability for Stage IA Nodular Lymphocyte Predominant Hodgkin Lymphoma. (Aldrink JH, Appel B, Kaplan JA, Hutchison RE, Schwartz CL, Kelly KM, McCarten K, Ehrlich PF) J Pediatr Hematol Oncol 2018 Apr;40(3):246-247 PMID: 29401099 PMCID: PMC5866194 02/06/2018    
  • Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma. (Welch JJG, Schwartz CL, Higman M, Chen L, Buxton A, Kanakry JA, Kahwash SB, Hutchison RE, Friedman DL, Ambinder RF) Blood Adv 2017 Apr 25;1(11):681-684 PMID: 29296710 PMCID: PMC5727814 01/04/2018    
  • Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis. (Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM) Cancer 2018 01 01;124(1):136-144 PMID: 28902390 PMCID: PMC5735034 09/14/2017       10 Citations
  • Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group. (Untanu RV, Back J, Appel B, Pei Q, Chen L, Buxton A, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL, Hutchison RE) Pediatr Blood Cancer 2018 Jan;65(1) PMID: 28802087 PMCID: PMC5699946 08/13/2017       4 Citations
  • Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report. (Fernández KS, Schwartz CL, Chen L, Constine LS, Chauvenet A, de Alarcón PA) Pediatr Blood Cancer 2017 Dec;64(12) PMID: 28612375 PMCID: PMC5799083 06/15/2017       5 Citations
  • Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia. (Esbenshade AJ, Zhao Z, Aftandilian C, Saab R, Wattier RL, Beauchemin M, Miller TP, Wilkes JJ, Kelly MJ, Fernbach A, Jeng M, Schwartz CL, Dvorak CC, Shyr Y, Moons KGM, Sulis ML, Friedman DL) Cancer 2017 Oct 01;123(19):3781-3790 PMID: 28542918 PMCID: PMC5610619 05/26/2017       2 Citations
  • Understanding predictors of continued long-term pediatric cancer care across the region: A report from the Consortium for New England Childhood Cancer Survivors. (Welch JJG, Kenney LB, Hirway P, Usmani GN, Kadan-Lottick N, Grewal SS, Huang M, Bradeen H, Ader J, Diller L, Schwartz CL) Pediatr Blood Cancer 2017 Oct;64(10) PMID: 28453181 04/30/2017    
  • Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease. (Harrison DJ, Schwartz CL) Curr Treat Options Oncol 2017 04;18(4):24 PMID: 28391422 04/10/2017       10 Citations
  • Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial. (Charpentier AM, Friedman DL, Wolden S, Schwartz C, Gill B, Sykes J, Albert-Green A, Kelly KM, Constine LS, Hodgson DC) Int J Radiat Oncol Biol Phys 2016 12 01;96(5):943-950 PMID: 27869096 PMCID: PMC5584603 11/22/2016       2 Citations
  • Mental distress and health care use among survivors of adolescent and young adult cancer: A cross-sectional analysis of the National Health Interview Survey. (Kaul S, Avila JC, Mutambudzi M, Russell H, Kirchhoff AC, Schwartz CL) Cancer 2017 03 01;123(5):869-878 PMID: 27859009 11/20/2016       15 Citations
  • Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group. (Schwartz CL, Chen L, McCarten K, Wolden S, Constine LS, Hutchison RE, de Alarcon PA, Keller FG, Kelly KM, Trippet TA, Voss SD, Friedman DL) Pediatr Blood Cancer 2017 04;64(4) PMID: 27786406 PMCID: PMC5702912 10/28/2016       8 Citations
  • Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. (Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS) Lancet Oncol 2016 Oct;17(10):1396-1408 PMID: 27569442 PMCID: PMC5052459 08/30/2016       53 Citations
  • Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group. (Appel BE, Chen L, Buxton AB, Hutchison RE, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL) J Clin Oncol 2016 07 10;34(20):2372-9 PMID: 27185849 PMCID: PMC4981978 05/18/2016       14 Citations
  • Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee. (Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou AJ) Pediatr Blood Cancer 2016 10;63(10):1737-43 PMID: 27128693 PMCID: PMC5136499 04/30/2016       6 Citations
  • Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group. (Macpherson CF, Hooke MC, Friedman DL, Campbell K, Withycombe J, Schwartz CL, Kelly K, Meza J) J Adolesc Young Adult Oncol 2015 Sep;4(3):137-40 PMID: 26421221 PMCID: PMC4575513 10/01/2015       2 Citations
  • Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. (Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE) Pediatr Blood Cancer 2016 Jan;63(1):54-61 PMID: 26398490 PMCID: PMC4779061 09/24/2015       28 Citations
  • Pediatric Hodgkin Lymphoma. (Mauz-Körholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, Kluge R, Körholz D) J Clin Oncol 2015 Sep 20;33(27):2975-85 PMID: 26304892 08/26/2015       38 Citations
  • Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group. (Chow EJ, Asselin BL, Schwartz CL, Doody DR, Leisenring WM, Aggarwal S, Baker KS, Bhatia S, Constine LS, Freyer DR, Lipshultz SE, Armenian SH) J Clin Oncol 2015 Aug 20;33(24):2639-45 PMID: 26014292 PMCID: PMC4534526 05/28/2015       29 Citations
  • A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study. (Horton TM, Drachtman RA, Chen L, Cole PD, McCarten K, Voss S, Guillerman RP, Buxton A, Howard SC, Hogan SM, Sheehan AM, López-Terrada D, Mrazek MD, Agrawal N, Wu MF, Liu H, De Alarcon PA, Trippet TM, Schwartz CL) Br J Haematol 2015 Jul;170(1):118-22 PMID: 25833390 PMCID: PMC4478135 04/03/2015       13 Citations
  • Radiotherapy quality assurance report from children's oncology group AHOD0031. (Dharmarajan KV, Friedman DL, FitzGerald TJ, McCarten KM, Constine LS, Chen L, Kessel SK, Iandoli M, Laurie F, Schwartz CL, Wolden SL) Int J Radiat Oncol Biol Phys 2015 Apr 01;91(5):1065-71 PMID: 25670539 PMCID: PMC5240783 02/12/2015       6 Citations
  • Survivorship. (Harrison DJ, Schwartz C) J Surg Oncol 2015 Apr;111(5):648-55 PMID: 25557722 01/06/2015       6 Citations
  • Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group. (Dharmarajan KV, Friedman DL, Schwartz CL, Chen L, FitzGerald TJ, McCarten KM, Kessel SK, Iandoli M, Constine LS, Wolden SL) Int J Radiat Oncol Biol Phys 2015 May 01;92(1):60-6 PMID: 25542311 PMCID: PMC4395527 12/30/2014       11 Citations
  • Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031. (Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL) J Clin Oncol 2014 Nov 10;32(32):3651-8 PMID: 25311218 PMCID: PMC4220044 10/15/2014       70 Citations
  • Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report. (Trippett TM, Schwartz CL, Guillerman RP, Gamis AS, Gardner S, Hogan S, London WB, Chen L, de Alarcon P) Pediatr Blood Cancer 2015 Jan;62(1):60-4 PMID: 25308760 PMCID: PMC4465390 10/14/2014       8 Citations
  • HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. (Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N) Pediatr Blood Cancer 2014 Sep;61(9):1558-64 PMID: 24753182 PMCID: PMC4288578 04/23/2014       9 Citations
  • ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma. (Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS) Pediatr Blood Cancer 2014 Jul;61(7):1305-12 PMID: 24616347 03/13/2014       7 Citations
  • Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study. (Borinstein SC, Barkauskas DA, Bernstein M, Goorin A, Gorlick R, Krailo M, Schwartz CL, Wexler LH, Toretsky JA) Pediatr Blood Cancer 2014 Apr;61(4):749-52 PMID: 24178953 PMCID: PMC3946315 11/02/2013       7 Citations
  • Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group. (Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, de Alarcón PA, Schwartz C, Chauvenet A) Pediatr Blood Cancer 2012 Dec 15;59(7):1259-65 PMID: 22911615 PMCID: PMC3468662 08/23/2012       42 Citations
  • Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group. (Voss SD, Chen L, Constine LS, Chauvenet A, Fitzgerald TJ, Kaste SC, Slovis T, Schwartz CL) J Clin Oncol 2012 Jul 20;30(21):2635-40 PMID: 22689804 PMCID: PMC4559601 06/13/2012       47 Citations
  • Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group. (Janeway KA, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N) Cancer 2012 Sep 15;118(18):4597-605 PMID: 22252521 PMCID: PMC4008337 01/19/2012       81 Citations
  • The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: a report from the Consortium for New England Childhood Cancer Survivors. (Kenney LB, Bradeen H, Kadan-Lottick NS, Diller L, Homans A, Schwartz CL) Pediatr Blood Cancer 2011 Dec 01;57(6):1062-6 PMID: 21910208 09/13/2011       24 Citations
  • ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II. (Das P, Ng A, Constine LS, Advani R, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ) J Am Coll Radiol 2011 May;8(5):302-8 PMID: 21531305 05/03/2011    
  • The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. (Vrooman LM, Neuberg DS, Stevenson KE, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Larsen EC, Laverdière C, Michon B, Schorin M, Schwartz CL, Cohen HJ, Lipshultz SE, Silverman LB, Sallan SE) Eur J Cancer 2011 Jun;47(9):1373-9 PMID: 21514146 PMCID: PMC3736806 04/26/2011       72 Citations
  • Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report. (Cole PD, McCarten KM, Drachtman RA, Alarcon Pd, Chen L, Trippett TM, Schwartz CL) Pediatr Hematol Oncol 2010 Nov;27(8):650-7 PMID: 20863157 PMCID: PMC3083978 09/25/2010       1 Citations
  • Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma. (Loeb DM, Hobbs RF, Okoli A, Chen AR, Cho S, Srinivasan S, Sgouros G, Shokek O, Wharam MD Jr, Scott T, Schwartz CL) Cancer 2010 Dec 01;116(23):5470-8 PMID: 20715156 PMCID: PMC2991401 08/18/2010       14 Citations
  • ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma. (Ng A, Constine LS, Advani R, Das P, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ) Curr Probl Cancer 2010 May-Jun;34(3):211-27 PMID: 20541059 06/15/2010       26 Citations
  • Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498). (Fitzgerald TJ, Bishop-Jodoin M, Cicchetti MG, Hanusik R, Kessel S, Laurie F, McCarten KM, Moni J, Pieters RS, Rosen N, Ulin K, Urie M, Chauvenet AR, Constine LS, Deye J, Vikram B, Friedman D, Marcus RB Jr, Mendenhall NP, Williams JL, Purdy J, Saltz J, Schwartz CL, White KS, Wolden S) Int J Radiat Oncol Biol Phys 2010 May 01;77(1):315-6 PMID: 20394859 PMCID: PMC2908913 04/17/2010       5 Citations
  • Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). (Silverman LB, Stevenson KE, O'Brien JE, Asselin BL, Barr RD, Clavell L, Cole PD, Kelly KM, Laverdiere C, Michon B, Schorin MA, Schwartz CL, O'Holleran EW, Neuberg DS, Cohen HJ, Sallan SE) Leukemia 2010 Feb;24(2):320-34 PMID: 20016537 PMCID: PMC2820141 12/18/2009    
  • Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. (Silverman LB, Supko JG, Stevenson KE, Woodward C, Vrooman LM, Neuberg DS, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Laverdière C, Michon B, Schorin M, Schwartz CL, O'Brien JE, Cohen HJ, Sallan SE) Blood 2010 Feb 18;115(7):1351-3 PMID: 20007809 PMCID: PMC2826760 12/17/2009       62 Citations
  • Bacteremia in febrile nonneutropenic pediatric oncology patients. (Kelly MJ, Vivier PM, Panken TM, Schwartz CL) Pediatr Blood Cancer 2010 Jan;54(1):83-7 PMID: 19774640 09/24/2009       13 Citations
  • A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. (Schwartz CL, Constine LS, Villaluna D, London WB, Hutchison RE, Sposto R, Lipshultz SE, Turner CS, deAlarcon PA, Chauvenet A) Blood 2009 Sep 03;114(10):2051-9 PMID: 19584400 PMCID: PMC2744567 07/09/2009       115 Citations
  • Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. (Loeb DM, Garrett-Mayer E, Hobbs RF, Prideaux AR, Sgouros G, Shokek O, Wharam MD Jr, Scott T, Schwartz CL) Cancer 2009 Jun 01;115(11):2514-22 PMID: 19338063 PMCID: PMC2974628 04/02/2009       32 Citations
  • Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report. (Cole PD, Schwartz CL, Drachtman RA, de Alarcon PA, Chen L, Trippett TM) J Clin Oncol 2009 Mar 20;27(9):1456-61 PMID: 19224841 PMCID: PMC2668553 02/20/2009       33 Citations
  • Parental needs for information related to neurocognitive late effects from pediatric cancer and its treatment. (Trask CL, Welch JJ, Manley P, Jelalian E, Schwartz CL) Pediatr Blood Cancer 2009 Feb;52(2):273-9 PMID: 18985741 11/06/2008       18 Citations
  • Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. (Basu SK, Schwartz C, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS) Int J Radiat Oncol Biol Phys 2008 Sep 01;72(1):34-40 PMID: 18722264 PMCID: PMC3532026 08/30/2008       42 Citations
  • Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. (Constine LS, Tarbell N, Hudson MM, Schwartz C, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P, Sandhu A, Culakova E, Lyman G, Mendenhall N) Int J Radiat Oncol Biol Phys 2008 Sep 01;72(1):24-33 PMID: 18722263 PMCID: PMC3531236 08/30/2008       98 Citations
  • Allogeneic stem cell transplantation in a patient with relapsed Ewing sarcoma. (Lucas KG, Schwartz C, Kaplan J) Pediatr Blood Cancer 2008 Jul;51(1):142-4 PMID: 18266223 02/13/2008       21 Citations
  • Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. (Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE, Children's Oncology Group) J Clin Oncol 2008 Feb 01;26(4):633-8 PMID: 18235123 02/01/2008       413 Citations
  • Orthostatic intolerance in survivors of childhood cancer. (Terlou A, Ruble K, Stapert AF, Chang HC, Rowe PC, Schwartz CL) Eur J Cancer 2007 Dec;43(18):2685-90 PMID: 17689953 08/11/2007       3 Citations
  • Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing. (Hope WW, Seibel NL, Schwartz CL, Arrieta A, Flynn P, Shad A, Albano E, Keirns JJ, Buell DN, Gumbo T, Drusano GL, Walsh TJ) Antimicrob Agents Chemother 2007 Oct;51(10):3714-9 PMID: 17638696 PMCID: PMC2043253 07/20/2007       84 Citations
  • American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. (Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ, ASCO Cancer Survivorship Expert Panel) J Clin Oncol 2007 Sep 01;25(25):3991-4008 PMID: 17577017 06/20/2007       441 Citations
  • Motor and perceptual timing deficits among survivors of childhood leukemia. (Mahone EM, Prahme MC, Ruble K, Mostofsky SH, Schwartz CL) J Pediatr Psychol 2007 Sep;32(8):918-25 PMID: 17522113 05/25/2007       12 Citations
  • Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group. (Schwartz CL, Gorlick R, Teot L, Krailo M, Chen Z, Goorin A, Grier HE, Bernstein ML, Meyers P, Children's Oncology Group) J Clin Oncol 2007 May 20;25(15):2057-62 PMID: 17513810 05/22/2007       71 Citations
  • Monitoring diagnostic accuracy and complications. A report from the Children's Oncology Group Hodgkin lymphoma study. (Ehrlich PF, Friedman DL, Schwartz CL, Children Oncology Group Hodgkin Lymphoma study section) J Pediatr Surg 2007 May;42(5):788-91 PMID: 17502184 05/16/2007       9 Citations
  • Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. (Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P, Arceci RJ) Pediatr Blood Cancer 2008 Mar;50(3):667-70 PMID: 17318876 02/24/2007       20 Citations
  • Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. (Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL) J Clin Oncol 2007 Feb 10;25(5):493-500 PMID: 17290056 02/10/2007       233 Citations
  • Chronic health conditions in adult survivors of childhood cancer. (Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL, Childhood Cancer Survivor Study) N Engl J Med 2006 Oct 12;355(15):1572-82 PMID: 17035650 10/13/2006       1828 Citations
  • POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group. (Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR, Children's Oncology Group) J Pediatr Hematol Oncol 2006 Jun;28(6):362-8 PMID: 16794504 06/24/2006       64 Citations
  • Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. (Walsh TJ, Adamson PC, Seibel NL, Flynn PM, Neely MN, Schwartz C, Shad A, Kaplan SL, Roden MM, Stone JA, Miller A, Bradshaw SK, Li SX, Sable CA, Kartsonis NA) Antimicrob Agents Chemother 2005 Nov;49(11):4536-45 PMID: 16251293 PMCID: PMC1280172 10/28/2005       179 Citations
  • Sm-153 EDTMP for recurrent metastatic osteosarcoma. (Welsh JS, Thurman SA, Borzillary S, Schwartz CL, Howard SP) Clin Adv Hematol Oncol 2003 Mar;1(3):181-3; discussion 183 PMID: 16224400 10/15/2005       4 Citations
  • APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial. (Wimmer RS, Chauvenet AR, London WB, Villaluna D, de Alarcon PA, Schwartz CL) Pediatr Blood Cancer 2006 Mar;46(3):320-4 PMID: 16200630 10/04/2005       6 Citations
  • Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. (Seibel NL, Schwartz C, Arrieta A, Flynn P, Shad A, Albano E, Keirns J, Lau WM, Facklam DP, Buell DN, Walsh TJ) Antimicrob Agents Chemother 2005 Aug;49(8):3317-24 PMID: 16048942 PMCID: PMC1196271 07/29/2005       180 Citations
  • Special issues in pediatric Hodgkin's disease. (Schwartz CL) Eur J Haematol Suppl 2005 Jul(66):55-62 PMID: 16007870 07/13/2005       28 Citations
  • Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. (Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H) J Clin Oncol 2005 Mar 20;23(9):2004-11 PMID: 15774791 03/19/2005       415 Citations
  • Health status of adult long-term survivors of childhood cancer:a report from the Childhood Cancer Survivor Study. (Schwartz CL) J Pediatr 2004 Mar;144(3):407-8 PMID: 15032224 03/23/2004    
  • Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. (Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith MA, Toretsky J, Tsokos M, Wexler L, Wigginton J, Withrow S, Schoenfeldt M, Anderson B) Clin Cancer Res 2003 Nov 15;9(15):5442-53 PMID: 14654523 12/05/2003       137 Citations
  • Prognostic factors in pediatric Hodgkin disease. (Schwartz CL) Curr Oncol Rep 2003 Nov;5(6):498-504 PMID: 14521809 10/03/2003       13 Citations
  • Health status of childhood cancer survivors: cure is more than the eradication of cancer. (Schwartz CL) JAMA 2003 Sep 24;290(12):1641-3 PMID: 14506124 09/25/2003       25 Citations
  • Radiation-associated cardiovascular disease: manifestations and management. (Adams MJ, Lipshultz SE, Schwartz C, Fajardo LF, Coen V, Constine LS) Semin Radiat Oncol 2003 Jul;13(3):346-56 PMID: 12903022 08/07/2003       144 Citations
  • The management of Hodgkin disease in the young child. (Schwartz CL) Curr Opin Pediatr 2003 Feb;15(1):10-6 PMID: 12544266 01/25/2003       25 Citations
  • Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease. (Meij P, Vervoort MB, Bloemena E, Schouten TE, Schwartz C, Grufferman S, Ambinder RF, Middeldorp JM) J Med Virol 2002 Nov;68(3):370-7 PMID: 12226824 09/13/2002       25 Citations
  • Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. (Goorin AM, Harris MB, Bernstein M, Ferguson W, Devidas M, Siegal GP, Gebhardt MC, Schwartz CL, Link M, Grier HE) J Clin Oncol 2002 Jan 15;20(2):426-33 PMID: 11786570 01/12/2002       139 Citations
  • Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. (Lipton JM, Federman N, Khabbaze Y, Schwartz CL, Hilliard LM, Clark JI, Vlachos A, Diamond-Black Anemia Registry) J Pediatr Hematol Oncol 2001 Jan;23(1):39-44 PMID: 11196268 02/24/2001       91 Citations
  • Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia. (Schwartz CL, Thompson EB, Gelber RD, Young ML, Chilton D, Cohen HJ, Sallan SE) J Clin Oncol 2001 Feb 15;19(4):1040-6 PMID: 11181667 02/22/2001       51 Citations
  • Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. (Spunt SL, Lobe TE, Pappo AS, Parham DM, Wharam MD Jr, Arndt C, Anderson JR, Crist WM, Paidas C, Wiener E, Andrassy RJ, Schwartz CL) J Pediatr Surg 2000 Feb;35(2):309-16 PMID: 10693686 02/29/2000       84 Citations
  • Long-term survivors of childhood cancer: the late effects of therapy. (Schwartz CL) Oncologist 1999;4(1):45-54 PMID: 10337370 05/25/1999       132 Citations
  • Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. (Leung W, Chen AR, Klann RC, Moss TJ, Davis JM, Noga SJ, Cohen KJ, Friedman AD, Small D, Schwartz CL, Borowitz MJ, Wharam MD, Paidas CN, Long CA, Karandish S, McMannis JD, Kastan MB, Civin CI) Bone Marrow Transplant 1998 Nov;22(10):971-9 PMID: 9849694 12/16/1998       59 Citations
  • Osteosarcoma. (Dome JS, Schwartz CL) Cancer Treat Res 1997;92:215-51 PMID: 9494763 01/01/1997       9 Citations
  • NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network. (O'Reilly R, Link M, Fletcher B, Gebhardt M, Krance R, Meyers P, Neff J, Schwartz C) Oncology (Williston Park) 1996 Dec;10(12):1799-806, 1812 PMID: 8985965 12/01/1996       5 Citations
  • Late effects of treatment in long-term survivors of cancer. (Schwartz CL) Cancer Treat Rev 1995 Jul;21(4):355-66 PMID: 7585660 07/01/1995       37 Citations
  • Multiple drug resistance in osteosarcoma. (Rosier RN, Teot LA, Hicks DG, Schwartz C, O'Keefe RJ, Puzas JE) Iowa Orthop J 1995;15:66-73 PMID: 7634047 PMCID: PMC2329065 01/01/1995       6 Citations
  • Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer. (Schwartz CL, Hobbie WL, Truesdell S, Constine LC, Clark EB) J Clin Oncol 1993 Oct;11(10):1906-10 PMID: 8410117 10/01/1993       79 Citations
  • Transposition of the oncogene ets-1 in t(11;19) translocation in acute leukemia. (Wang N, Cedrone E, Dry J, Skuse GR, Schwartz C, Terryberry S) Cancer Genet Cytogenet 1990 Dec;50(2):199-205 PMID: 2265401 12/01/1990       2 Citations
  • Creating life on the plateau: reproductive potential in survivors of childhood Hodgkin's disease. (Schwartz CL) Int J Radiat Oncol Biol Phys 1990 Oct;19(4):1099-100 PMID: 2211248 10/01/1990       2 Citations
  • Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. (Schwartz C, Henrickson KJ, Roghmann K, Powell K) J Clin Oncol 1990 Sep;8(9):1591-7 PMID: 2202792 09/01/1990       174 Citations
  • Creating life on the plateau: Reproductive potential in survivors of childhood Hodgkin's disease (Schwartz CL) Int J Rad Onc Biol Phys (19):1099-1100 08/16/1990    
  • Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheter with vancomycin susceptible organisms. (Schwartz CL, Henrickson KJ, Roghmann K, Powell K.) J Clin Oncol (8):1591-1597 06/27/1990    
  • Still more on Tufts' student surgery program. J Am Vet Med Assoc 1990 Apr 01;196(7):1002-3, 1006 PMID: 2329065 04/01/1990    
  • The optic nerve as the site of initial relapse in childhood acute lymphoblastic leukemia. (Schwartz CL, Miller NR, Wharam MD, Leventhal BG) Cancer 1989 Apr 15;63(8):1616-20 PMID: 2635874 04/15/1989       24 Citations
  • Endocrine late effects among survivors of cancer. (Hobbie WL, Schwartz CL) Semin Oncol Nurs 1989 Feb;5(1):14-21 PMID: 2646663 02/01/1989       5 Citations
  • Preleukemic syndromes and other syndromes predisposing to leukemia. (Schwartz CL, Cohen HJ) Pediatr Clin North Am 1988 Aug;35(4):853-71 PMID: 3047657 08/01/1988       6 Citations
  • A dilute solution of vancomycin and heparin retains antibacterial and anticoagulant activities. (Henrickson KJ, Powell KR, Schwartz CL) J Infect Dis 1988 Mar;157(3):600-1 PMID: 3343531 03/01/1988       29 Citations
  • Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin. (Schwartz CL, Minniti CP, Harwood P, Na S, Banquerigo ML, Strauss LC, Kurtzberg J, Smith SD, Civin CI) J Clin Oncol 1987 Dec;5(12):1900-11 PMID: 3500279 12/01/1987       5 Citations
  • Rapid separation of whole human bone marrow aspirates by counterflow centrifugation elutriation. (Noga SJ, Schwartz CL, Civin CI, Loken M, Donnenberg AD) Transplantation 1987 Mar;43(3):438-40 PMID: 3547800 03/01/1987       5 Citations
  • Large scale separation of human bone marrow by counterflow centrifugation elutriation. (Noga SJ, Cremo CA, Duff SC, Schwartz CL, Melaragno A, Civin CI, Donnenberg AD) J Immunol Methods 1986 Sep 27;92(2):211-8 PMID: 2944969 09/27/1986       9 Citations
  • Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow. (Noga SJ, Donnenberg AD, Schwartz CL, Strauss LC, Civin CI, Santos GW) Transplantation 1986 Feb;41(2):220-9 PMID: 2935979 02/01/1986       35 Citations
  • QT interval prolongation and cardiac dysrhythmia in a patient receiving amsacrine. (Schwartz CL, Bender KS, Burke PJ, Kan JS, Civin CI) Cancer Treat Rep 1984 Jul-Aug;68(7-8):1043-4 PMID: 6547639 07/01/1984       5 Citations
  • Last update: 12/11/2018
    jenkins-FCD Prod-310 bff9d975ec7f2d302586822146c2801dd4449aad